| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/11/2006 | US20060099606 Assay to detect viral uncoating |
| 05/11/2006 | US20060099605 Devices and methods for isolating RNA |
| 05/11/2006 | US20060099604 Cysteamine moiety covalently attached to a phthalein, xanthene or naphthalimide dye or a fluorophore, chromophore, magnetic particle, gold particle, or isotopic mass label to form a target-associative tag for analyzing, identifying, or purifying phosphorylated proteins |
| 05/11/2006 | US20060099603 Method of diagnosis/prognosis of human chronic lymphocytic leukemia comprising the profiling of LPL/ADAM genes |
| 05/11/2006 | US20060099601 Novel compositions and processes for analyte detection, quantification and amplification |
| 05/11/2006 | US20060099600 Novel acetylcholine transporter |
| 05/11/2006 | US20060099599 Role of Glycogen Synthase Kinase-3 and tetraspanins in ethanol-induced henaviors |
| 05/11/2006 | US20060099598 Methods for diagnosis and monitoring of neurological disease by detection of an Encephalotoxin |
| 05/11/2006 | US20060099597 Method of isolating nucleic acid having desired functional property and kit therefor |
| 05/11/2006 | US20060099596 Multiplex assay detection of pathogenic organisms |
| 05/11/2006 | US20060099595 Culturing an Huh-7.5 cell line (ATCC accession number PTA-8561) that also has a genomic or subgenomic HCV RNA capable of replication, curing with an antiviral agent, and identifying sublines that are permissive for HCV replication. |
| 05/11/2006 | US20060099594 Method of predicting genetic risk for hypertension |
| 05/11/2006 | US20060099593 Method of diagnosing integration dysfunction syndrome using blood |
| 05/11/2006 | US20060099592 Method for the synthesis of a bifunctional complex |
| 05/11/2006 | US20060099591 Diagnosis of chronic rejection |
| 05/11/2006 | US20060099590 Method of diagnosing risk of restenosis after coronary angioplasty |
| 05/11/2006 | US20060099589 Gene shuffling by template switching |
| 05/11/2006 | US20060099588 producing an isolated polynucleotide sequence encoding chymosin which is modified so as to comprise at least one N X-T-glycosylation site and a method for producing such a polypeptide; milk clotting; cheesemaking |
| 05/11/2006 | US20060099587 Alphavirus vectors having attentuated virion structural proteins |
| 05/11/2006 | US20060099586 Eef1a2 for use in the prognosis, diagnosis, and treatment of cancer |
| 05/11/2006 | US20060099585 Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases |
| 05/11/2006 | US20060099584 A method for increasing the affinity of an oligonucleotide for a target nucleic acid |
| 05/11/2006 | US20060099583 Compositions and methods for identifying antiviral agents |
| 05/11/2006 | US20060099582 Determining an index of organ health in the course of transplantation therapy comprising measuring the expression level of peripheral-type benzodiazepine receptor (PBR); predictor of the outcome of transplantation therapy |
| 05/11/2006 | US20060099581 Method for analysis of methylated nucleic acids |
| 05/11/2006 | US20060099580 Methyl-cpg binding domain protein 2 homologs |
| 05/11/2006 | US20060099579 In situ induced antigen technology (isiat) for identification of polynucleotides expressed during infection or colonization |
| 05/11/2006 | US20060099578 Mitochondrial biology expression arrays |
| 05/11/2006 | US20060099577 Method for preparative production of long nucleic acids by pcr |
| 05/11/2006 | US20060099576 Method for diagnosing a pre-neoplastic or neoplastic lesion in transitional epithelial cells |
| 05/11/2006 | US20060099575 67 human secreted proteins |
| 05/11/2006 | US20060099574 Detection and distinguishing infections bursal disease virus (IBDV) strains by molecular biology method |
| 05/11/2006 | US20060099573 Diagnostic assays |
| 05/11/2006 | US20060099572 Contacting each of a plurality of reagents in separate compartments with compound, wherein each reagent has a predetermined concentration of two types of precipitating agents comprising salt and polyoxyethylene glycol; human immunodeficiency polypeptide viral polypeptides; |
| 05/11/2006 | US20060099571 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment |
| 05/11/2006 | US20060099570 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle |
| 05/11/2006 | US20060099569 Method and device for diagnosing oncological diseases |
| 05/11/2006 | US20060099568 Signals and molecular species involved in senescence |
| 05/11/2006 | US20060099327 Method for producing polymer layers |
| 05/11/2006 | US20060099225 Generation of virus-like particles and use as panfilovirus vaccine |
| 05/11/2006 | US20060099224 Methods and compositions concerning poxviruses and cancer |
| 05/11/2006 | US20060099221 Method of screening anti-mycobacterial molecules |
| 05/11/2006 | US20060099220 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 05/11/2006 | US20060099219 Mutated hpv-16e7 polypeptide, pharmaceutical composition comprising it and its preparation process |
| 05/11/2006 | US20060099214 Cancer-linked gene as target for chemotherapy |
| 05/11/2006 | US20060099210 for screening for modulators for treating mental disorders such as bipolar disorder, schizophrenia and depression; polypeptides; polynucleotides; vectors; host cells |
| 05/11/2006 | US20060099209 prostate and breast carcinoma; used for diagnosis to identify individuals with the high probability of having a malignant disease |
| 05/11/2006 | US20060099199 Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof |
| 05/11/2006 | US20060099174 Interferon-alpha induced genes |
| 05/11/2006 | US20060099147 Functionalized encapsulated fluorescent nanocrystals |
| 05/11/2006 | US20060099142 Cancer associated araf1 protein kinase and its uses |
| 05/11/2006 | US20060097863 Tracking equipment |
| 05/11/2006 | US20060097056 Encoding of microcarriers |
| 05/11/2006 | US20060096859 Determining concentration of hydrogen peroxide using organic quaternary ammonium or phosphonium ferricyanide compound which in reduced form functions as mediator specific to hydrogen peroxide; detected electrochemically at potential of -400 mV (Ag/AgCl) where oxidation of common interferants is avoided |
| 05/11/2006 | US20060096858 Potentiometric urea sensor based on ion-selective electrode |
| 05/11/2006 | DE3571648C5 Monoklonale Antikörper gegen menschlichen Brustkrebs, ihre Produktion und Verwendung, Hybridomen zu ihrer Herstellung und Herstellung dieser Hybridomen. Monoclonal antibodies against human breast cancer, their production and use, hybridomas for their preparation and production of these hybridomas. |
| 05/11/2006 | DE102004053918A1 Aptamerbasiertes Testsystem Aptamerbasiertes test system |
| 05/11/2006 | DE102004052889A1 Screeningverfahren zur Früherkennung des zerebralen Vasospasmus Screening method for early detection of cerebral vasospasm |
| 05/11/2006 | CA2589129A1 A method, an installation, and a computer program for estimating the initial size of a population of nucleic acids, in particular by pcr |
| 05/11/2006 | CA2586874A1 Method of diagnosis/prognosis of human chronic lymphocytic leukemia comprising the profiling of lpl/adam genes |
| 05/11/2006 | CA2586848A1 Method of detecting platelet thrombosis or organ injury |
| 05/11/2006 | CA2586299A1 Method for detecting or enriching a target microorganism upon lysis of non-target bacteria with bacteriophage |
| 05/11/2006 | CA2586275A1 Identification and use of mirnas for differentiating myelogenous leukaemia cells |
| 05/11/2006 | CA2586246A1 Single step nucleic acid detection assay employing reverse transcription, polymerase chain reaction and endonuclease cleavage |
| 05/11/2006 | CA2586201A1 Transcriptome microarray technology and methods of using the same |
| 05/11/2006 | CA2585203A1 Nucleic acid primers and probes for detecting breast cells |
| 05/11/2006 | CA2585005A1 Membrane filter for microbe detection |
| 05/10/2006 | EP1655607A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
| 05/10/2006 | EP1655605A2 Treatment and diagnosis of cancer |
| 05/10/2006 | EP1655602A2 Systems and methods for processing nucleic acid chromatograms |
| 05/10/2006 | EP1655382A2 Colon specific gene and protein |
| 05/10/2006 | EP1655381A1 Nucleic acid labeling methods |
| 05/10/2006 | EP1655380A2 Map-based genome mining method for identifying regulatory loci controlling the level of gene transcripts and products |
| 05/10/2006 | EP1655379A1 Method, apparatus and kit for analyzing sample nucleic acid |
| 05/10/2006 | EP1655378A1 Method for quantifying and assessing the viability of neospora caninum in samples of bovine semen |
| 05/10/2006 | EP1655377A1 Method of quantifying methylated DNA |
| 05/10/2006 | EP1655369A1 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 05/10/2006 | EP1655367A1 Modulators of tissue regeneration |
| 05/10/2006 | EP1655069A1 Modified molecular arrays |
| 05/10/2006 | EP1654686A2 Methods and system for multi-drug treatment discovery |
| 05/10/2006 | EP1654685A2 Systems and methods for sequence comparison |
| 05/10/2006 | EP1654537A2 Tssk4: a human testis specific serine/threonine kinase |
| 05/10/2006 | EP1654533A2 Bridged element for detection of a target substance |
| 05/10/2006 | EP1654526A2 Biomarker panel for colorectal cancer |
| 05/10/2006 | EP1654390A2 Liquid crystal based analyte detection |
| 05/10/2006 | EP1654389A2 Sample preparation methods and devices |
| 05/10/2006 | EP1654388A2 Method for the detection of cytosine methylations in dna |
| 05/10/2006 | EP1654387A2 Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample |
| 05/10/2006 | EP1654386A2 Methods for analyzing transcripts |
| 05/10/2006 | EP1654385A2 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment |
| 05/10/2006 | EP1654384A2 Method and kit for assessing the risk of cardiovascular pathologies with atheromatous etiology |
| 05/10/2006 | EP1654383A1 Materials and methods for colorectal cancer screening, diagnosis, and therapy |
| 05/10/2006 | EP1654382A1 Screening assay for anti-bacterial compounds |
| 05/10/2006 | EP1654381A1 A rapid method to detect nucleic acid molecules |
| 05/10/2006 | EP1654380A2 Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof |
| 05/10/2006 | EP1654377A2 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER |
| 05/10/2006 | EP1654372A2 Membrane transportable fluorescent substrates |
| 05/10/2006 | EP1654371A2 Methods for the manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes |
| 05/10/2006 | EP1654356A1 Improved halohydrin dehalogenases and related polynucleotides |
| 05/10/2006 | EP1654355A2 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products |